BioCorRx Inc
OTC:BICX
BioCorRx Inc
OTC:BICX
Price:
0.255
USD
-12.07%
Market Closed
Market Cap:
$6m
Balance Sheet
Balance Sheet Decomposition
BioCorRx Inc
BioCorRx Inc
Balance Sheet Decomposition is not available for
BioCorRx Inc
BioCorRx Inc
Balance Sheet
BioCorRx Inc
BioCorRx Inc
Currency: USD
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
4
|
4
|
4
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
5
+45 000%
|
5
+13%
|
4
-13%
|
4
-8%
|
1
-65%
|
0
-67%
|
0
-28%
|
1
+85%
|
4
+524%
|
2
-53%
|
1
-55%
|
1
-6%
|
0
-49%
|
0
-1%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
4
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
2
|
1
|
2
|
4
|
2
|
2
|
6
|
3
|
3
|
4
|
5
|
6
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
5
|
1
|
0
|
2
|
3
|
3
|
4
|
4
|
4
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
+1 700%
|
1
+467%
|
2
+121%
|
4
+87%
|
4
-10%
|
5
+24%
|
9
+83%
|
4
-51%
|
6
+48%
|
5
-22%
|
6
+21%
|
8
+29%
|
9
+15%
|
10
+16%
|
13
+22%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
1
|
2
|
5
|
9
|
13
|
19
|
49
|
55
|
61
|
65
|
70
|
74
|
78
|
83
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
4
|
4
|
6
|
9
|
10
|
11
|
45
|
50
|
60
|
61
|
63
|
66
|
68
|
71
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
3
-19%
|
0
-92%
|
0
+41%
|
3
N/A
|
8
-148%
|
4
+52%
|
6
-45%
|
1
+83%
|
4
-317%
|
7
-67%
|
8
-18%
|
10
-22%
|
12
-23%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
5
+45 000%
|
5
+13%
|
4
-13%
|
4
-8%
|
1
-65%
|
0
-67%
|
0
-28%
|
1
+85%
|
4
+524%
|
2
-53%
|
1
-55%
|
1
-6%
|
0
-49%
|
0
-1%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
0
|
5
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
5
|
5
|
7
|
8
|
9
|
13
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
